EUVIMEDEUVIMED entdecken
Open Access · CC0

Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies

Taylor B Engdahl iD, Elad Binshtein, Rebecca L Brocato, Natalia A Kuzmina, Lucia M Principe, Steven A Kwilas iD, Robert K Kim, Nathaniel S Chapman, Monique S Porter, Pablo Guardado-Calvo iD, Félix A Rey iD, Laura S Handal und 10 weitere

eLife · 27.03.2023 · 12

DOI: 10.7554/elife.81743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 27.03.2023. Verfasst von Taylor B Engdahl und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States. Hauptthemen laut MEDLINE: Orthohantavirus, Hantavirus Infections, Hantaan virus, Communicable Diseases. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIH HHS, NIGMS NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hantaviruses are high-priority emerging pathogens carried by rodents and transmitted to humans by aerosolized excreta or, in rare cases, person-to-person contact. While infections in humans are relatively rare, mortality rates range from 1 to 40% depending on the hantavirus species. There are currently no FDA-approved vaccines or therapeutics for hantaviruses, and the only treatment for infection is supportive care for respiratory or kidney failure. Additionally, the human humoral immune response to hantavirus infection is incompletely understood, especially the location of major antigenic sites on the viral glycoproteins and conserved neutralizing epitopes. Here, we report antigenic mapping and functional characterization for four neutralizing hantavirus antibodies. The broadly neutralizing antibody SNV-53 targets an interface between Gn/Gc, neutralizes through fusion inhibition and cross-protects against the Old World hantavirus species Hantaan virus when administered pre- or post-exposure. Another broad antibody, SNV-24, also neutralizes through fusion inhibition but targets domain I of Gc and demonstrates weak neutralizing activity to authentic hantaviruses. ANDV-specific, neutralizing antibodies (ANDV-5 and ANDV-34) neutralize through attachment blocking and protect against hantavirus cardiopulmonary syndrome (HCPS) in animals but target two different antigenic faces on the head domain of Gn. Determining the antigenic sites for neutralizing antibodies will contribute to further therapeutic development for hantavirus-related diseases and inform the design of new broadly protective hantavirus vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrthohantavirusHantavirus InfectionsHantaan virusCommunicable DiseasesAnimalsHumansAntibodies, NeutralizingAntibodies, ViralRodentia

Stichwörter der Autor:innen

Andes virusHantaan virusSin Nombre virusantibodybunyavirushantavirusimmunologyinflammationviruses

Substanzen

Antibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, United States.
  • Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, United States.
  • Virology Division, United States Army Medical Research Institute of Infectious Diseases, Ft Detrick, United States.
  • Department of Pathology, The University of Texas Medical Branch at Galveston, Galveston, United States.
  • Galveston National Laboratory, Galveston, United States.
  • Institut Pasteur, Université Paris Cité, Paris, France.

ORCID-Profile: Taylor B Engdahl, Steven A Kwilas, Pablo Guardado-Calvo, Félix A Rey, Jens Meiler, Alexander Bukreyev, James E Crowe

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Military Infectious Diseases Program
  • NIH Office of the Director

Zitieren

APA

Engdahl, T. B., Binshtein, E., Brocato, R. L., Kuzmina, N. A., Principe, L. M., Kwilas, S. A., Kim, R. K., Chapman, N. S., Porter, M. S., Guardado-Calvo, P., Rey, F. A., Handal, L. S., Diaz, S. M., Zagol-Ikapitte, I. A., Tran, M. H., McDonald, W. H., Meiler, J., Reidy, J. X., Trivette, A., …, & Crowe, J. E. (2023). Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies. eLife, 12. https://doi.org/10.7554/elife.81743

Vancouver

Engdahl TB, Binshtein E, Brocato RL, Kuzmina NA, Principe LM, Kwilas SA, et al. Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies. eLife. 2023;12. doi:10.7554/elife.81743

BibTeX
@article{Engdahl2023,
  author = {Engdahl, Taylor B and Binshtein, Elad and Brocato, Rebecca L and Kuzmina, Natalia A and Principe, Lucia M and Kwilas, Steven A and Kim, Robert K and Chapman, Nathaniel S and Porter, Monique S and Guardado-Calvo, Pablo and Rey, Félix A and Handal, Laura S and Diaz, Summer M and Zagol-Ikapitte, Irene A and Tran, Minh H and McDonald, W Hayes and Meiler, Jens and Reidy, Joseph X and Trivette, Andrew and Bukreyev, Alexander and Hooper, Jay W and Crowe, James E},
  title = {Antigenic mapping and functional characterization of human New World hantavirus neutralizing antibodies},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.81743}
}
Kostenlos starten →